Intest Res.  2023 Jul;21(3):277-279. 10.5217/ir.2023.00076.

Diagnosis, management, and prevention of infectious complications in inflammatory bowel disease: variations among Asian countries

• Baek JE
• Hwang SW

• KMID: 2544750
• DOI: http://doi.org/10.5217/ir.2023.00076

Reference

1. Park SH. Update on the epidemiology of inflammatory bowel disease in Asia: where are we now? Intest Res. 2022; 20:159–164.

2. Annese V, Duricova D, Gower-Rousseau C, Jess T, Langholz E. Impact of new treatments on hospitalisation, surgery, infection, and mortality in IBD: a focus paper by the Epidemiology Committee of ECCO. J Crohns Colitis. 2016; 10:216–225.

3. Hibi T, Kamae I, Pinton P, et al. Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis. Intest Res. 2021; 19:53–61.

4. Beaugerie L, Rahier JF, Kirchgesner J. Predicting, preventing, and managing treatment-related complications in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2020; 18:1324–1335.

5. Kucharzik T, Ellul P, Greuter T, et al. ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease. J Crohns Colitis. 2021; 15:879–913.

6. Jun YK, Koh SJ, Myung DS, et al. Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting. Intest Res. 2023; 21:353–362.

7. Merican I, Guan R, Amarapuka D, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol. 2000; 15:1356–1361.

8. Yang H, Ran Z, Jin M, Qian JM. Current status of opportunistic infection in inflammatory bowel disease patients in Asia: a questionnaire-based multicenter study. Gut Liver. 2022; 16:726–735.

9. McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018; 66:e1–e48.

10. Sterling TR, Njie G, Zenner D, et al. Guidelines for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm Rep. 2020; 69:1–11.